Table 4.
Survival related factors.
| Survivors | Exitus | P-value | |
|---|---|---|---|
| Demographic data | |||
| Female | (n = 8) 16% | (n = 12) 24% | 0.815 |
| Male | (n = 1) 26% | (n = 17) 34 % | |
| Body weight (kg) | 7.5 | 16.5 | 0.084 |
| Age (month) | 4 | 37 | 0.017 |
| Intensive Care Monitoring | |||
| PRISM score | 20 | 29 | 0.016 |
| PELOD score | 17 | 31 | 0.001 |
| Duration of hospitalization in PICU/NICU (days) | 16.5 | 5 | 0.192 |
| Biochemical data at the onset of CRRT | |||
| BUN (mg/dL) | 13 | 27 | 0.157 |
| Creatinine (mg/dL) | 1.03 | 1.26 | 0.120 |
| Sodium (mEq/L) | 137 | 138 | 0.679 |
| Potassium (mEq/L) | 3.7 | 4.3 | 0.032 |
| Urine Output (ml/kg/h) | 1.82 | 0.78 | 0.026 |
| CRRT duration (hours) | 72 | 72 | 0.992 |
| CRRT modality | |||
| CVVHF | (n=0) | (n= 2) 4% | 0.321 |
| CVVHD | (n= 7) 14% | (n= 5) 10% | |
| CVVHDF | (n= 14) 28% | (n= 22) 44% | |
| Vascular access location | |||
| Femoral | (n= 5) 10% | (n= 13) 26% | 0.277 |
| Jugular | (n= 13) 26% | (n= 11) 22% | |
| Subclavian | (n= 3) 6% | (n= 4) 8% | |
| ECMO set | (n= 0) | (n= 1) 2% | |
| Catheter size | 7 | 9 | 0.435 |
| CRRT prescription | |||
| Blood flow rate | 6.4 | 4.4 | 0.02 |
| Mean circuit lifespan (hours) | 42 | 30 | 0.283 |